Furthermore, activation of complement C5 is strongly associated with the inflammatory microenvironment of diabetic kidneys, while blockade of C5aR by C5a receptor antagonists prevents endothelial‐mesenchymal transition (EndMT) and alleviates fibrosis in the glomeruli of individuals with DKD.7, 8. The gene discussed is C5AR1; the disease is diabetic kidney disease.